Literature DB >> 12091675

Recurrent laryngeal nerve palsy in patients with lung cancer: detection with PET-CT image fusion -- report of six cases.

Ehab M Kamel1, Gerhard W Goerres, Cyrill Burger, Gustav K von Schulthess, Hans C Steinert.   

Abstract

Positron emission tomography (PET) with fluorodeoxyglucose (FDG) was performed for preoperative staging of lung cancer. In six of 184 patients, there was an intense FDG accumulation in the lower anterior neck. Fusion of PET and computed tomographic images revealed that the focal FDG uptake was localized in the internal laryngeal muscles. This finding was a result of compensatory laryngeal muscle activation caused by contralateral recurrent laryngeal nerve palsy due to direct nerve invasion by lung cancer of the left mediastinum or lung apices. The knowledge of this pitfall is important to avoid false-positive PET results.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12091675     DOI： 10.1148/radiol.2241011254

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


  13 in total

Review 1.  PET/CT: a new imaging technology in nuclear medicine.

Authors:  Heiko Schöder; Yusuf E Erdi; Steven M Larson; Henry W D Yeung
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-05       Impact factor: 9.236

2.  Value of PET-CT fusion imaging in avoiding potential pitfalls in the interpretation of 18F-FDG accumulation in the distal oesophagus.

Authors:  Lucia Rampin; Cristina Nanni; Stefano Fanti; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08       Impact factor: 9.236

Review 3.  False-positive FDG PET uptake--the role of PET/CT.

Authors:  Sandra J Rosenbaum; Thomas Lind; Gerald Antoch; Andreas Bockisch
Journal:  Eur Radiol       Date:  2005-12-17       Impact factor: 5.315

4.  FDG-PET/CT can rule out malignancy in patients with vocal cord palsy.

Authors:  Anders Thomassen; Anne Lerberg Nielsen; Jeppe Kiilerich Lauridsen; Björn Alexander Blomberg; Søren Hess; Henrik Petersen; Allan Johansen; Jon Thor Asmussen; Jesper Roed Sørensen; Jørgen Johansen; Christian Godballe; Poul Flemming Høilund-Carlsen
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

5.  2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography of the head and neck: an atlas of normal uptake and variants.

Authors:  Steven C Burrell; Annick D Van den Abbeele
Journal:  Mol Imaging Biol       Date:  2005 May-Jun       Impact factor: 3.488

6.  [PET/CT in lymphoma patients].

Authors:  H C Steinert
Journal:  Radiologe       Date:  2004-11       Impact factor: 0.635

Review 7.  Role and cost effectiveness of PET/CT in management of patients with cancer.

Authors:  Muhammad Wasif Saif; Ifigenia Tzannou; Nektaria Makrilia; Kostas Syrigos
Journal:  Yale J Biol Med       Date:  2010-06

Review 8.  PET/CT in malignant lymphoma: basic information, clinical application, and proposal.

Authors:  Ukihide Tateishi
Journal:  Int J Hematol       Date:  2013-09-25       Impact factor: 2.490

9.  Radiation exposure during transmission measurements: comparison between CT- and germanium-based techniques with a current PET scanner.

Authors:  Tung-Hsin Wu; Yung-Hui Huang; Jason J S Lee; Shih-Yuan Wang; Su-Cheng Wang; Cheng-Tau Su; Liang-Kung Chen; Tieh-Chi Chu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-08       Impact factor: 9.236

10.  Physiologic [18F]fluorodeoxyglucose uptake of floor of mouth muscles in PET/CT imaging: a problem of body position during FDG uptake?

Authors:  Stephan K Haerle; Thomas F Hany; Nader Ahmad; Irene Burger; Gerhard F Huber; Daniel T Schmid
Journal:  Cancer Imaging       Date:  2013-02-20       Impact factor: 3.909
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.